Latest News

Date Title Topic
16 Jun 2017 NICE Issues Technology Appraisal Guidance for Brentuximab Vedotin in CD30-Positive Hodgkin Lymphoma Haematologic malignancies - Anticancer agents & Biologic therapy
15 Jun 2017 Press Release: Annals of Oncology in Top 10 Oncology Journals
15 Jun 2017 World GI 2017 Media Alert: Coming Soon – World’s Largest Gastrointestinal Cancer Congress
14 Jun 2017 Guide for Patients in Ovarian Cancer Now Available Also in Serbian
14 Jun 2017 EMA – PRAC Concludes There Is No Evidence of a Change in Known Risk of Neutropenic Enterocolitis With Docetaxel Anticancer agents & Biologic therapy
13 Jun 2017 FDA Approves Aminolevulinic Acid Hydrochloride as an Optical Imaging Agent Indicated in Patients with Gliomas Diagnosis, Imaging and Staging - Central nervous system malignancies
13 Jun 2017 ESMO 2019 Press Release: Annual Congress to be held in Barcelona
12 Jun 2017 T-DM1 in HER2 Overexpressing, Amplified or Mutated Metastatic NSCLC Translational research - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
09 Jun 2017 Routine Molecular Screening of Advanced Refractory Cancer Patients Personalised medicine
08 Jun 2017 EMA Adopts a Negative Opinion for Human IgG1 mAb Specific for Human Interleukin-1 Alpha XBiotech Gastrointestinal cancers
08 Jun 2017 2017 WHO Cancer Resolution: Cancer prevention and control in the context of an integrated approach
eUpdate - Algorithms
07 Jun 2017 Three Biosimilar Medicines with Rituximab as Active Substance Received a Positive Opinion from EMA Haematologic malignancies
06 Jun 2017 NICE Issues Quality Standard for Haematological Cancers Haematologic malignancies